ODI Pharma AB: Publication of year-end report for the fiscal year 2021/2022
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its year-end report for the period July 2021 – June 2022. The report is available as an attached document to this press release and on the Company’s website (www.odipharma.com). Below is a summary of the report.Fourth quarter (2022-04-01 – 2022-06-30) The Group's net sales amounted to SEK 14,233 (0). The Group's loss after financial items amounted to SEK -2,378,022 (-1,886,158). Result per share amounted to SEK -0,16 (-0,12).* The solidity as of 2022-06-30 was 88,48% (96,55%).** Fiscal year (2021-07-01 – 2022-06-30)